JPMORGAN CHASE & CO - GEMINI THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 52 filers reported holding GEMINI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$14,000
-53.3%
10,274
-2.6%
0.00%–
Q4 2021$30,000
-67.7%
10,552
-54.3%
0.00%–
Q3 2021$93,000
+72.2%
23,068
+174.3%
0.00%–
Q2 2021$54,000
+31.7%
8,410
+180.3%
0.00%–
Q1 2021$41,000–3,000–0.00%–
 Download
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Running Point Capital Advisors, LLC 10,000$13,5000.01%
Ulland Investment Advisors, LLC 0$00.00%
View complete list of GEMINI THERAPEUTICS INC shareholders